{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:54:36Z","timestamp":1782982476486,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Tissue Viability"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtv.2024.09.008","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T23:00:50Z","timestamp":1727737250000},"page":"608-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of neuropathy in epidermal growth factor administered patients diagnosed with diabetic foot"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-3367","authenticated-orcid":false,"given":"\u00dcmran","family":"\u00d6zdemir Sipahio\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakine","family":"Boyraz \u00d6zkavak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtv.2024.09.008_bib1","first-page":"4","article-title":"Atlas Reports Diabetes foot-related complications, Diabetes-related peripheral neuropathy and peripheral arterial disease","year":"2022","journal-title":"IDF Diab Atlas"},{"key":"10.1016\/j.jtv.2024.09.008_bib2","unstructured":"The International Working Group on the Diabetic Foot (IWGDF) Guidelines. IWGDF Practical guidelines on the prevention and management of diabetic foot disease. Part of the 2019: 6-180 www.iwgdfguidelines.org. [Accessed 4 March 2023]."},{"key":"10.1016\/j.jtv.2024.09.008_bib3","series-title":"Treatment and monitoring guide","article-title":"Turkish endocrinology and metabolism association (TEMD), diabetes mellitus and complications diagnosis","year":"2022"},{"issue":"5","key":"10.1016\/j.jtv.2024.09.008_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00125-008-0940-0","article-title":"Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study","volume":"51","author":"Prompers","year":"2008","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.jtv.2024.09.008_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis","volume":"49","author":"Zhang","year":"2017","journal-title":"Ann Med"},{"key":"10.1016\/j.jtv.2024.09.008_bib6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/medicina57101072","article-title":"Diabetic wound-healing science","volume":"57","author":"Burgess","year":"2021","journal-title":"Medicina"},{"issue":"3","key":"10.1016\/j.jtv.2024.09.008_bib7","first-page":"224","article-title":"New applications in wound care","volume":"3","author":"Vural","year":"2017","journal-title":"Turkiye Klinikleri Surgical Nursing-Special Topics"},{"issue":"1","key":"10.1016\/j.jtv.2024.09.008_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1531003512442093","article-title":"Epidermal growth factor in the treatment of diabetic foot ulcers: an update","volume":"24","author":"Tiaka","year":"2012","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"key":"10.1016\/j.jtv.2024.09.008_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","article-title":"Growth factors and cytokines in wound healing","volume":"16","author":"Barrientos","year":"2008","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jtv.2024.09.008_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.msec.2014.07.039","article-title":"Enhancement of skin wound healing with decellularized scaffolds loaded with hyaluronic acid and epidermal growth factor","volume":"44","author":"Su","year":"2014","journal-title":"Mater Sci Eng C"},{"issue":"1","key":"10.1016\/j.jtv.2024.09.008_bib11","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1007\/s10856-014-5322-1","article-title":"Decellularized scaffolds containing hyaluronic acid and EGF for promoting the recovery of skin wounds","volume":"26","author":"Wu","year":"2015","journal-title":"J Mater Sci Mater Med"},{"issue":"3","key":"10.1016\/j.jtv.2024.09.008_bib12","first-page":"560","article-title":"Current treatment approaches and nursing care in the management of diabetic neuropathy","volume":"12","author":"G\u00f6rg\u00fcl\u00fc","year":"2022","journal-title":"Value in Health Sciences"},{"key":"10.1016\/j.jtv.2024.09.008_bib13","author":"Avcu"},{"issue":"6","key":"10.1016\/j.jtv.2024.09.008_bib14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","article-title":"Diabetic somatic neuropathies","volume":"27","author":"Boulton","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtv.2024.09.008_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8549567","article-title":"Evaluation of nurses knowledge levels of diabetic foot care management","author":"Kaya","year":"2018","journal-title":"Nursing Research And Practice"},{"issue":"4","key":"10.1016\/j.jtv.2024.09.008_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.54029\/2021huu","article-title":"Questionnaires can reflect the severity of electrophysiological findings in diabetic patients","volume":"26","author":"Beton","year":"2021","journal-title":"Neurol Asia"},{"key":"10.1016\/j.jtv.2024.09.008_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jdiacomp.2015.08.008","article-title":"Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population","volume":"29","author":"Spanos","year":"2015","journal-title":"J Diabetes Complicat"},{"issue":"Suppl 1","key":"10.1016\/j.jtv.2024.09.008_bib18","doi-asserted-by":"crossref","first-page":"e3266","DOI":"10.1002\/dmrr.3266","article-title":"Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)","volume":"36","author":"Schaper","year":"2020","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"2","key":"10.1016\/j.jtv.2024.09.008_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1742-481X.2009.00594.x","article-title":"The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results","volume":"6","author":"Tuyet","year":"2009","journal-title":"Int Wound J"},{"issue":"5","key":"10.1016\/j.jtv.2024.09.008_bib20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2337\/dc07-2367","article-title":"Use of the SINBAD classification system and score \u0130n comparing outcome of foot ulcer management on three continents","volume":"31","author":"Ince","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jtv.2024.09.008_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3959(00)00482-6","article-title":"The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs","volume":"92","author":"Bennett","year":"2001","journal-title":"Pain"},{"issue":"No 8","key":"10.1016\/j.jtv.2024.09.008_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jpain.2004.07.001","article-title":"Results of the leeds assessment of neuropathic symptoms and signs pain scale in Turkey: a validation study","volume":"5","author":"Yucel","year":"2004","journal-title":"J Pain"},{"issue":"5","key":"10.1016\/j.jtv.2024.09.008_bib23","first-page":"576","article-title":"Comprehensive foot examination and risk assessment. A report of task force of the foot care interest group of the American diabetes association","volume":"14","author":"Boulton","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jtv.2024.09.008_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.diabres.2005.02.013","article-title":"A comparison of the monofilament with other testing modalities for foot ulcer susceptibility","volume":"70","author":"Miranda-Palma","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jtv.2024.09.008_bib25","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.2337\/dc22-S012","article-title":"Retinopathy, neuropathy, and foot care: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtv.2024.09.008_bib26","first-page":"355","article-title":"Measurement, evaluation and classification of diabetic foot wounds","volume":"14","author":"Toklu","year":"2015","journal-title":"TOTBID J."},{"issue":"1","key":"10.1016\/j.jtv.2024.09.008_bib27","first-page":"65","article-title":"Foot ulcers in the diabetic patient, prevention and treatment","volume":"3","author":"Wu","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jtv.2024.09.008_bib28","series-title":"Appropriate statistical test selection guide","author":"Kul","year":"2014"},{"issue":"1","key":"10.1016\/j.jtv.2024.09.008_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1742-481X.2008.00561.x","article-title":"Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure","volume":"6","author":"Fernandez-Montequ\u0131n","year":"2009","journal-title":"Int Wound J"},{"issue":"3","key":"10.1016\/j.jtv.2024.09.008_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.30795\/jfootankle.2022.v16.1652","article-title":"Study of the clinical aspect of diabetic foot ulcers and its surgical management","volume":"16","author":"Shukla","year":"2022","journal-title":"J. Foot. Ankle"},{"issue":"2","key":"10.1016\/j.jtv.2024.09.008_bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.18203\/2349-2902.isj20200301","article-title":"A prospective study to determine the application of site, ischemia, neuropathy, bacterial infection and depth scoring in the outcome and management of diabetic foot ulcers","volume":"7","author":"Venkataramana","year":"2020","journal-title":"Int. Surg. J."},{"key":"10.1016\/j.jtv.2024.09.008_bib32","article-title":"Use of the SINBAD score as a predicting tool for major adverse foot events in patients with diabetic foot ulcer: a French multicentre study","volume":"39","author":"Ha","year":"2023","journal-title":"Diabetes Metabolism Research and Reviews"},{"key":"10.1016\/j.jtv.2024.09.008_bib33","series-title":"Diabetic medicine","article-title":"On behalf of the members of the National Foot Care Audit Steering Group Research: complications Pilot study to assess measures to be used in the prospective audit of the management of foot ulcers in people with diabetes","author":"Holman","year":"2014"},{"issue":"3","key":"10.1016\/j.jtv.2024.09.008_bib34","first-page":"277","article-title":"Intralesional application of epidermal growth factor \u0130n limb-threatening \u0130schemic diabetic foot ulcers","volume":"50","author":"Akta\u015f","year":"2016","journal-title":"Acta Orthop Traumatol Turcica"},{"issue":"1","key":"10.1016\/j.jtv.2024.09.008_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.25083\/2559.5555\/7.1.7","article-title":"The effect of human recombinant epidermal growth factor in the treatment of diabetic foot ulcers","volume":"7","author":"Bart\u0131n","year":"2022","journal-title":"J Clini Inves. Surg."},{"issue":"6","key":"10.1016\/j.jtv.2024.09.008_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.16899\/jcm.1143566","article-title":"Experience in a epidermal growth factor use in diabetic foot ulcers","volume":"12","author":"Baykan","year":"2022","journal-title":"J Contemp Med"},{"issue":"1","key":"10.1016\/j.jtv.2024.09.008_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5578\/turkjsurg.4541","article-title":"Intralesional epidermal growth factor application is a potential therapeutic strategy to improve diabetic foot ulcer healing and prevent amputation","volume":"36","author":"\u00c7etinkaya","year":"2020","journal-title":"Turkish J.Surg."},{"issue":"1","key":"10.1016\/j.jtv.2024.09.008_bib38","first-page":"1","article-title":"Intralesional epidermal growth factor treatment on diabetic foot ulcers: one centre experience","volume":"1","author":"\u00c7ifci","year":"2018","journal-title":"J. Health Sci Med"},{"issue":"2","key":"10.1016\/j.jtv.2024.09.008_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/08977194.2015.1031898","article-title":"Efficacy of intralesional recombinant human epidermal growth factor in chronic diabetic foot ulcers","volume":"33","author":"Dumantepe","year":"2015","journal-title":"Growth Factors"},{"issue":"4","key":"10.1016\/j.jtv.2024.09.008_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1742-481X.2007.00344.x","article-title":"Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation","volume":"4","author":"Fernandez-Montequ\u0131\u0131n","year":"2007","journal-title":"Int Wound J"},{"key":"10.1016\/j.jtv.2024.09.008_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/wrr.12187","article-title":"Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial","volume":"22","author":"Gomez-Villa","year":"2014","journal-title":"Wound Repair Regen"},{"issue":"3","key":"10.1016\/j.jtv.2024.09.008_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5336\/dermato.2022-90463","article-title":"The effect of intralesional human epidermal growth factor on wound healing in chronic diabetic foot ulcer: a retrospective analysis of patient results","volume":"32","author":"G\u00f6k\u015fin","year":"2022","journal-title":"Turkiye Klinikleri J Derma"},{"issue":"3","key":"10.1016\/j.jtv.2024.09.008_bib43","first-page":"278","article-title":"Intralesional epidermal growth factor for diabetic foot ulcers","volume":"32","author":"Ilkeli","year":"2022","journal-title":"J Colla Physi Surg Pakistan: JCPSP."},{"key":"10.1016\/j.jtv.2024.09.008_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.jfas.2018.08.041","article-title":"The long-term outcomes following the application of intralesional epidermal growth factor in patients with diabetic foot ulcers","volume":"58","author":"Kahraman","year":"2019","journal-title":"J Foot Ankle Surg"},{"issue":"Sup4","key":"10.1016\/j.jtv.2024.09.008_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12968\/jowc.2023.32.Sup4.S14","article-title":"Intralesional epidermal growth factor therapy in recalcitrant diabetic foot ulcers","volume":"32","author":"\u00d6zker","year":"2023","journal-title":"J Wound Care"},{"issue":"3","key":"10.1016\/j.jtv.2024.09.008_bib46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1742-481X.2011.00796.x","article-title":"Insensate foot of diabetic foot ulcer can have underlying silent neuropathic pain","volume":"8","author":"Yunus","year":"2011","journal-title":"Int Wound J"},{"issue":"10","key":"10.1016\/j.jtv.2024.09.008_bib47","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1464-5491.2002.00801.x","article-title":"The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study","volume":"19","author":"Oyibo","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.jtv.2024.09.008_bib48","first-page":"629","article-title":"Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management","volume":"27","author":"Tesfaye","year":"2011","journal-title":"D\u0131abetes\/Metabol\u0131sm Research And Rev\u0131ews"},{"issue":"3","key":"10.1016\/j.jtv.2024.09.008_bib49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jnr.490300306","article-title":"Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: comparison with basic fibroblast growth factor","volume":"30","author":"Ferrari","year":"1991","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jtv.2024.09.008_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.3498986","article-title":"Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor","volume":"238","author":"Morrison","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.jtv.2024.09.008_bib51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2017.10.037","article-title":"JAK2\/STAT3 pathway is involved in the protective effects of epidermal growth factor receptor activation against cerebral ischemia\/reperfusion injury in rats","volume":"662","author":"Tang","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jtv.2024.09.008_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2006.04.039","article-title":"Enhanced neurogenesis in the ischemic striatum following EGF-induced expansion of transit-amplifying cells in the subventricular zone","volume":"403","author":"Ninomiya","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jtv.2024.09.008_bib53","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI200317170","article-title":"EGF amplifies the replacement of parvalbumin-expressing striatal interneurons after ischemia","volume":"111","author":"Teramoto","year":"2003","journal-title":"J Clin Invest"},{"issue":"Issue: 2","key":"10.1016\/j.jtv.2024.09.008_bib54","first-page":"99","article-title":"Neuroprotective effects of epidermal growth factor","volume":"31","author":"Yar\u0131m","year":"2017","journal-title":"F\u0131rat University Health Sciences Medical Journal"},{"issue":"6","key":"10.1016\/j.jtv.2024.09.008_bib55","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2337\/diacare.26.6.1856","article-title":"Human epidermal growth factor enhances healing of diabetic foot ulcers","volume":"26","author":"Tsang","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtv.2024.09.008_bib56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1742-481X.2006.00237.x","article-title":"Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds","volume":"3","author":"Acosta","year":"2006","journal-title":"Int Wound J"}],"container-title":["Journal of Tissue Viability"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965206X2400144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965206X2400144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T22:56:54Z","timestamp":1745881014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965206X2400144X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0965206X2400144X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtv.2024.09.008","relation":{},"ISSN":["0965-206X"],"issn-type":[{"value":"0965-206X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of neuropathy in epidermal growth factor administered patients diagnosed with diabetic foot","name":"articletitle","label":"Article Title"},{"value":"Journal of Tissue Viability","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtv.2024.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Tissue Viability Society \/ Society of Tissue Viability. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}